Please login to the form below

Not currently logged in
Email:
Password:

Dr Stephen Hoffman joins Bicycle Therapeutics

He becomes chairman of the board

Cambridge, UK-headquartered Bicycle Therapeutics has named Dr Stephen Hoffman as chairman of its board of directors.

Dr Hoffman brings 30 years of experience in the pharmaceutical and financial industries to the biotech, currently serving as a senior advisor to PDL BioPharma and president of 10x Capital, an investment management firm.

He is also a member of the board of directors of AcelRx Pharmaceuticals, Dicerna Pharmaceuticals and Genocea Biosciences.

Previously, Dr Hoffman was managing director at Skyline Ventures from 2005 to 2014, and served as president, chairman, chief executive officer and director of Allos Therapeutics between 1994 and 2012.

Kevin Lee, chief executive of Bicycle Therapeutics, said: “Stephen has significant global healthcare experience and a strong track record of creating new medicines to address important unmet patient needs across a range of diseases, including oncology.

“We are pleased to welcome Stephen as our board chairman, and believe his experience founding, building and advising biotechnology companies will be instrumental in guiding the company as we develop innovative new cancer medicines and further advance our proprietary platform.” 

21st July 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics